1. Cross-Border Regulatory Architecture for Foreign Target Companies
Foreign businesses entering the U.S. .apital markets through a Business Combination Agreement face overlapping regulatory frameworks that require precise cross-border coordination.
Antitrust and Premerger Review Mechanics
Section 7A of the Clayton Act (15 U.S.C. § 18a), enacted under the Hart-Scott-Rodino Antitrust Improvements Act, mandates Premerger notification filings for cross-border transactions meeting applicable monetary thresholds, including the 2026 threshold of $133.9 million. The U.S. Federal Trade Commission (FTC) and the Department of Justice (DOJ) review these notices to evaluate potential anti-competitive market concentration during a SPAC Transaction.
2. Sec Disclosure Obligations and Foreign Private Issuer Qualification
Evaluating whether the target entity qualifies as a Foreign Private Issuer (FPI) shapes the disclosure timeline and compliance obligations under federal securities regulations.
Criteria for Foreign Private Issuer Status
FPI status under Rule 405 of the Securities Act (17 C.F.R. § 230.405) and Rule 3b-4 of the Exchange Act (17 C.F.R. § 240.3b-4) offers significant administrative advantages under broader Securities Regulations, including exemptions from Section 14 proxy rules and quarterly Form 10-Q reporting obligations.
To maintain FPI status, the non-U.S. .ompany must satisfy specific operational and ownership criteria:
Over 50 percent of outstanding voting securities must be directly or indirectly owned by non-U.S. .esidents.
The majority of executive officers and directors must not be U.S. .itizens or residents, and over 50 percent of corporate assets must be located outside the United States.
Financial Reconciliation and Internal Controls
When preparing the combined proxy statement and registration statement on Form F-4, target companies must reconcile foreign accounting standards with U.S. GAAP or International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). Pursuant to Sarbanes-Oxley Act Section 404 (15 U.S.C. § 7262), the combined public enterprise must establish internal control over financial reporting to meet public company reporting standards upon closing.
3. New York Law Principles Governing Transaction Agreements
New York law frequently serves as the governing legal framework for cross-border De-SPAC agreements due to established commercial precedents under state statutory law.
Statutory Choice of Law and Jurisdictional Validity
Section 5-1401 of the New York General Obligations Law validates statutory choice-of-law provisions in contracts covering obligations of $250,000 or more, regardless of whether the transaction bears a reasonable relation to the state. This framework provides cross-border commercial parties with statutory certainty during complex Mergers & Acquisitions. In addition, Section 5-1402 of the New York General Obligations Law permits foreign parties to submit to the jurisdiction of New York courts for transactions exceeding $1,000,000, ensuring predictable judicial enforcement in the Commercial Division of the New York State Supreme Court or the U.S. District Court for the Southern District of New York (SDNY).
Contractual Risk Allocation Mechanics
Cross-border agreement drafting requires precise contractual allocation of regulatory risk between the U.S. SPAC sponsor and the foreign target entity. Material Adverse Effect (MAE) provisions must specifically carve out international macroeconomic shifts, tariff modifications, and home-country regulatory changes. Indemnification and escrow arrangements must incorporate cross-border tax considerations, currency conversion mechanics, and enforceability under foreign civil procedure laws. Regulatory effort covenants, such as "reasonable best efforts," must explicitly define the required degree of divestiture or operational mitigation if CFIUS or antitrust regulators impose conditions.
4. Post-Closing Corporate Governance and Dual-Jurisdiction Obligations
Achieving a successful listing on NYSE or NASDAQ requires aligning the foreign target company's governance structure with stock exchange rules and federal law.
Stock Exchange Governance Exemptions
Stock exchange rules in the U.S. Capital Markets permit foreign private issuers to follow home-country corporate governance practices in lieu of certain exchange requirements, provided the company discloses these exemptions in its annual report on Form 20-F.
Mandatory Federal Governance Controls
However, cross-border public entities must comply with mandatory federal requirements regardless of home-country exemptions:
- Audit committees must consist entirely of independent directors pursuant to Exchange Act Rule 10A-3 (17 C.F.R. § 240.10A-3).
- Chief Executive Officers and Chief Financial Officers must issue personal certifications under Sarbanes-Oxley Act Sections 302 and 906, and institutional insider reporting rules under Section 16 apply to all FPI directors and officers as of March 2026.
Experienced legal advisors work to harmonize dual-filing timelines, shareholder meeting notice requirements under foreign corporate statutes, and SEC public disclosure schedules to prevent regulatory default.
5. Common Pitfalls and Mitigation in Cross-Border Spac Mergers
Mismatched regulatory timelines and foreign statutory requirements frequently generate friction during international SPAC merger execution.
Restructuring and Approval Friction
Currency and tax friction can arise when transferring foreign shares into the U.S. .ublic holding company structure without proper cross-border restructuring. Shareholder approval delays occur if local company law requires higher voting thresholds or court sanction procedures, as seen in scheme of arrangement jurisdictions.
Sanctions compliance under Office of Foreign Assets Control (OFAC) regulations requires comprehensive screening of foreign target investors, beneficial owners, and supply chains. Early legal coordination mitigates these operational vulnerabilities by establishing clear escrow protocols, foreign legal opinions, and regulatory contingency options prior to executing the definitive Business Combination Agreement.
10 Aug, 2026
